Patient groups heartened by shift in govt's rare diseases stance

They're 'cautiously optimistic' that more treatments will be added

The Federal Government will consider more applications to fund expensive medications for the treatment of patients with rare diseases after a review urged it to focus on quality of life rather than longevity.


Patient groups say they are “cautiously optimistic” that more treatments will be added to the government’s Life-Saving Drugs Program, with ministers saying they will open it up to allow for the listing of drugs that improve the quality of patients' lives.

The program, which pays for patients to access drugs that have been rejected by